

HY-163925 · 50 mg
MedChemExpress · Cat: HY-163925
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/lu-aazta-ni-psma-093.html
Description
Lu-AAZTA-NI-PSMA-093 enhances tumor uptake and retention by combining a hypoxia-sensitive nitroimidazole NI moiety with a targeting moiety to PSMA. Lu-AAZTA-NI-PSMA-093 can be used in prostate cancer.







